OHRP News and Press, Ohr Pharmaceutical Inc. From 03/06/19

CORAL GABLES, FL / ACCESSWIRE / March 6, 2019 / The tech stock market has been a hotbed of exciting conversation during the last few months as a result of word spreading about tech companies taking innovative approaches to create new technologies for the betterment of humankind. Stemming f...

Gainers:  Bio-Path Holdings (NASDAQ: BPTH ) +180% . Renren (NYSE: RENN ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +28% . Abercrombie & Fitch (NYSE: ANF ) +24% . Aytu BioScience (NASDAQ: AYTU ) +24% . OHR Pharmaceutical (NASDAQ: OHRP ) +23% . Proteon Therapeutics (NASDAQ: P...

Thinly traded nano cap Ohr Pharmaceutical ( OHRP +23% ) bucks the sector's down day on more than 5x higher volume. More news on: Ohr Pharmaceutical, Inc., Healthcare stocks news, Stocks on the move, Read more ...

NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) (the "...

Thinly traded nano cap Ohr Pharmaceuticals ( OHRP +38% ) is up on almost a 17x surge in volume on no particular news. More news on: Ohr Pharmaceutical, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Gainers:  3Pea International (NASDAQ: TPNL ) +22% . Gemphire Therapeutics (NASDAQ: GEMP ) +19% . Hanesbrands (NYSE: HBI ) +18% . OHR Pharmaceutical (NASDAQ: OHRP ) +16% . Chipotle Mexican Grill (NYSE: CMG ) +14% . ION Geophysical (NYSE: IO ) +15% . CSG Systems International (NAS...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The market is moving in the right direction after some cooling off of Washington-Be...

NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (Nasdaq: OHRP) announced today that its board of directors has determined to effect a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001...